{"id":"W1953576045","doi":"10.1160/th15-02-0181","title":"Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation","year":2015,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Daiichi-Sankyo; Daiichi Sankyo Europe; AstraZeneca","keywords":"Edoxaban; Medicine; Atrial fibrillation; Cardiology; Rivaroxaban; Internal medicine; Thrombosis; Anesthesia; Intensive care medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001604402,0.0006151508,0.001702607,0.002980205,0.0002585726,0.001201874,0.0009864781,0.001551422,0.002756356],"category_scores_gemma":[0.003204608,0.0003052156,0.001200396,0.002723229,0.0005243446,0.001554408,0.0007769649,0.00181971,0.0006733849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007553394,"about_ca_system_score_gemma":0.001726603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001987141,"about_ca_topic_score_gemma":0.003910356,"domain_scores_codex":[0.9990658,0.0003205506,0.0002152063,0.00008729459,0.0002725963,0.00003859121],"domain_scores_gemma":[0.998625,0.0009476962,0.0002085109,0.00002182827,0.0001649508,0.00003185454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009115659,0.00005465253,0.0002955274,0.06335273,0.0004614741,0.0001406927,0.0001289656,0.0002311761,0.0003543229,0.003450855,0.01396346,0.9174749],"study_design_scores_gemma":[0.0001612276,0.0001774051,0.002596386,0.084969,0.001699534,0.002042826,0.0002849925,0.0002140864,0.000398534,0.00541009,0.901994,0.0000518577],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007310367,0.9992194,0.00004121186,0.0003193342,0.00007454857,0.000003062557,0.000006713845,0.000001443712,0.0002611445],"genre_scores_gemma":[0.0006740334,0.998759,0.0001317501,0.000262182,0.0000700842,0.000004377256,0.00001101997,6.066317e-7,0.00008686624],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002980205,"threshold_uncertainty_score":0.009220958,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3592720851501375,"score_gpt":0.4737790191518197,"score_spread":0.1145069340016822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}